author-photo

Veerendra Munugalavadla

Indiana University
Genentech

69

Papers

1020

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

Entospletinib in Combination With Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 expression.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Ibrutinib Off-Target Inhibition Inhibits Antibody-Dependent Cellular Phagocytosis but Not Efferocytosis of CLL Cells

2020 Blood
Show All
- Source
- Cite
- Save
Citations (2)
High Surface Expression of CD49d (VLA-4) and CD79b Correlates with Acalabrutinib Resistance in Patients with Chronic Lymphocytic Leukemia (CLL)

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma

2019 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (9)
Acalabrutinib with Obinutuzumab in Treatment-Naive (TN) and Relapsed/Refractory (R/R) Patients with Chronic Lymphocytic Leukemia (CLL): 3-Year Follow-Up

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Acalabrutinib with obinutuzumab (Ob) in treatment-naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): Three-year follow-up.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab

2019 Leukemia
Show All
- Source
- Cite
- Save
Citations (10)
ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL).

2019 Blood
Show All
- Source
- Cite
- Save
Citations (38)
Anti-CD20 Therapy Reliance on Antibody-Dependent Cellular Phagocytosis Affects Combination Drug Choice

2019 Blood
Show All
- Source
- Cite
- Save
Citations (2)
A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia

2018 Oncotarget
Show All
- Source
- Cite
- Save
Citations (5)